Statera Biopharma, Inc. (STAB)

OTCMKTS: STAB · Delayed Price · USD
0.0006
0.00 (0.00%)
Feb 23, 2024, 3:21 PM EST - Market closed

Statera Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011 - 2006
Cost of Revenue
0.49000000000
Upgrade
Gross Profit
-0.49000000000
Upgrade
Selling, General & Admin
18.495.242.232.322.53.386.368,47012,03911,116
Upgrade
Research & Development
11.835.260.593.625.056.57.149,65419,52622,502
Upgrade
Other Operating Expenses
-1.49-0.46-0.290000000
Upgrade
Operating Expenses
28.8310.52.815.947.559.8713.518,12431,56533,617
Upgrade
Operating Income
38.68-10.5-2.81-4.8-5.6-6.36-10.79-14,421.94-23,076.76-30,046.61
Upgrade
Interest Expense
-4.561.130.12000.26-0.1-1,089.5883.13-70.02
Upgrade
Other Expense / Income
145.110.460.29-1.194.11-3.961.95-14,961.46-5,897.01-11,742.45
Upgrade
Pretax Income
-101.88-12.09-3.22-3.61-9.71-2.66-12.641,629-17,262.88-18,234.14
Upgrade
Income Tax
72.531.130.120000000
Upgrade
Net Income
-174.41-13.22-3.35-3.61-9.71-2.66-12.641,629-17,262.88-18,234.14
Upgrade
Shares Outstanding (Basic)
35262611111172,70345,00337,389
Upgrade
Shares Outstanding (Diluted)
35262611111172,70345,00337,389
Upgrade
Shares Change
36.88%-127.11%0.91%1.87%55.62%-99.74%-93.99%20.36%14.82%
Upgrade
EPS (Basic)
-4.97-0.52-0.13-0.32-0.87-0.24-1.790.60-0.38-0.49
Upgrade
EPS (Diluted)
-4.97-0.52-0.13-0.32-0.87-0.24-1.790.60-0.38-0.49
Upgrade
Free Cash Flow
-28.38-5.09-0.24-4.61-6.61-5.04-12.08-14,455.19-23,102.65-20,649.5
Upgrade
Free Cash Flow Per Share
-0.81-0.20-0.01-0.41-0.59-0.46-1.71-5.35-0.51-0.55
Upgrade
EBITDA
38.93-10.5-2.81-4.8-5.6-6.36-10.79-14,421.94-23,076.76-30,046.61
Upgrade
Depreciation & Amortization
0.2600.010.020.020.060.14200.79376.21479.6
Upgrade
EBIT
38.68-10.5-2.83-4.82-5.62-6.42-10.93-14,622.73-23,452.97-30,526.2
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.